H.R. 3551 (102nd): To amend the Internal Revenue Code of 1986, to extend the credit for clinical testing expenses for certain drugs for rare diseases or conditions, to impose a windfall profit tax on such drugs if they become excessively profitable, and for other purposes.
Oct 10, 1991
102nd Congress, 1991–1992
Died in a previous Congress
This bill was introduced on October 10, 1991, in a previous session of Congress, but was not enacted.
Fortney “Pete” Stark
Representative for California's 9th congressional district
About the bill
- Summary (CRS)
- Amends the Internal Revenue Code to extend through 1993 the tax credit for clinical testing expenses for certain drugs for rare diseases or conditions.Includes preclinical testing expenses under such tax ...
- What is a bill?
The “H.R.” in “H.R. 3551” means this is a House of Representatives bill in the United States Congress. A bill must be passed by both the House and Senate in identical form and then be signed by the President to become law.
The bill’s title was written by its sponsor.
- Committee Assignments
The committee chair determines whether a bill will move past the committee stage.
There have been no votes related to this bill.
- Subject Areas
- Find Similar Bills
Search for similar bills.
Links & tools
Click a format for a citation suggestion:
Civic Impulse. (2015). H.R. 3551 — 102nd Congress: To amend the Internal Revenue Code of 1986, to extend the credit for clinical testing .... Retrieved from https://www.govtrack.us/congress/bills/102/hr3551
“H.R. 3551 — 102nd Congress: To amend the Internal Revenue Code of 1986, to extend the credit for clinical testing ....” www.GovTrack.us. 1991. May 7, 2015 <https://www.govtrack.us/congress/bills/102/hr3551>
|title=H.R. 3551 (102nd)
|accessdate=May 7, 2015
|author=102nd Congress (1991)
|date=October 10, 1991
|quote=To amend the Internal Revenue Code of 1986, to extend the credit for clinical testing ...